2020 Virtual Annual Meeting

10/22: Virtual Annual Meeting Kick-Off - A Conversation with Director Iancu

October 22, 2020 12:00 PM to 1:00 PM

Location

Virtual

Join AIPLA President Barbara Fiacco for a conversation with the Honorable Andrei Iancu, Under Secretary of Commerce for Intellectual Property and Director of the USPTO as we welcome attendees to the first ever AIPLA Virtual Annual Meeting.

With thanks to the AIPLA Professional Programs Committee, coordinators, moderators, and speakers for helping put together these incredible CLE programs, and the AIPLA’s Committee Leadership and Sponsors for hosting a number of virtual networking meet ups, programs, happy hours, and other sessions.

We’re excited for an engaging fun 8 days, as we all connect from our remote locations, around the globe. If you miss a session, don’t worry. If you have the Full Meeting Package, you will have access to all of the recordings for every CLE session. Individual sessions remain available if you’d prefer to pick and choose sessions.

This session is not CLE accredited

Speakers

  • Iancu square200 Iancu, Andrei

    United States Patent and Trademark Office | Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office

    In his role as the Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office (USPTO), Andrei Iancu provides leadership and oversight to one of the largest intellectual property offices in the world, with more than 12,000 employees and an annual budget of over $3 billion. He also serves as the principal advisor to the Secretary of Commerce on domestic and international intellectual property policy matters.
  • Barbara Fiaco Barbara A. Fiacco

    Foley Hoag, LLP | AIPLA President-Elect

    Barbara Fiacco is Co-Chair of the Patent Litigation Practice and represents clients in complex intellectual property and patent litigation matters. Her technology-related practice focuses on the biomedical field, including counsel to companies with activities focusing on recombinant DNA, monoclonal antibodies, small molecule compounds, drug delivery, molecular diagnostics, and medical devices. She has defended pharmaceutical and life sciences clients in significant patent infringement lawsuits that have resulted in summary judgment or other favorable outcomes for her clients. Barbara is also the current President of AIPLA